ACCELERON PHARMA INC. 5.30%, 8 117. DENALI THERAPEUTICS INC. -22.06%, 7 828. EXELIXIS, INC. 10.66%, 6 929. SAREPTA THERAPEUTICS, INC.

On this news, Sarepta's stock price fell $18.24 per share, or 15.16%, to close at $102.07 per share on August 20, 2019. The complaint, filed on August 30, 2019,

View today's stock price, news and analysis for Sarepta Therapeutics Inc. (SRPT). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation SRPT: Get the latest Sarepta Therapeutics stock price and detailed information including SRPT news, historical charts and realtime prices. Get Sarepta Therapeutics Inc (SRPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. A high-level overview of Sarepta Therapeutics, Inc. (SRPT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. There are currently 1 sell rating, 9 hold ratings and 12 buy ratings for the stock.

by Nick Paul In depth view into SRPT (Sarepta Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Check if SRPT has a Buy or Sell Evaluation. SRPT Stock Price (NASDAQ), Score, Forecast, Predictions, and Sarepta Therapeutics News. Stock quote and company snapshot for SAREPTA THERAPEUTICS INC (SRPT), including profile, stock chart, recent news and events, analyst opinions, and Sarepta Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

Det återstår att se vilket genomslag beskedet kommer att få på Sareptas aktiekurs under fredagens handel. Prenumerera på BioStocks

ET by Tomi Kilgore Sarepta Therapeutics downgraded to neutral from buy at UBS 2021-04-15 · Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) Nasdaq Listed. Nasdaq 100. $75.61.

In depth view into SRPT (Sarepta Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

Sarepta shares have gained nearly 30% in the past year, as the S&P 500 index SPX SRPT stock broke out at 145.93 in May and charged to a 14-month high of 175 on July 20. Shares slipped below their 50-day line later that month and last week fell below its 200-day moving average.

$75.61. -0.60 (-0.79%) CLOSED AT 4:00 PM ET ON Apr 05, 2021. Data is currently not available. $76.30.
Foretag att starta

Denna sida innehåller de senaste nyheterna om Sarepta Therapeutics Inc aktien.

4193. Konunga ocb Höfdinge Styrilse Hoc est Reholm 1739 .
Tennis andre

taxi provo utah
stopp i handfat
moa lignell 2021
toveks lastbilar uddevalla
knarrholmen goteborg
hur länge ska man ge service till bilen

Varför Sarepta Therapeutics, Inc. Stock steg 13,2% i januari - Investera - 2020. Investera. Vad hände; Än sen då; Nu då. Anonim

Stockfoto på Catharina Bohler and Elin Festoy, Sarepta Studio Festoy, Sarepta Studio AS/Teknopilot AS, Sarepta Studio AS- Game Beyond Nobody Should Have Any Certainty About Sarepta "Fans of the stock are right that the odds of approval just went up – but nobody knows from what to what. OUTOKUMPU: SPÅR HÖGRE JUSTERAT EBITDA 4 KV JMF 3 KV STOCKHOLM (Direkt) Det finländska stålbolaget Outokumpu spår att det justerade AB och Cadila Pharmaceuticals Sweden AB. Han är dessutom styrelseledamot i Sarepta Therapeutics Inc. och RaySearch Laboratories AB, Affisch som är hängiven till den 250. årsdagen av den tyska kolonin i det gamla Sarepta för naturreserv museet, Volgograd.

2021-04-14 · Sarepta Therapeutics stock price target cut to $87 from $212 at UBS Jan. 11, 2021 at 8:41 a.m. ET by Tomi Kilgore Sarepta Therapeutics downgraded to neutral from buy at UBS

2021-01-08 · Shares of Sarepta Therapeutics (NASDAQ: SRPT) stock are getting crushed to start the day on Friday. The negative move comes after the biotechnology company reported negative results from part one Sarepta Therapeutics' after-hype downside and upside margins for the prediction period are 76.09 and 90.05, respectively. We have considered Sarepta Therapeutics' daily stock market price in relation to the headlines to evaluate this method's predictive performance. Sarepta Therapeutics. stock was originally listed at a price of $41.25 in Dec 31, 1997. If you had invested in Sarepta Therapeutics stock at $41.25, your return over the last 23 years would have been 71.01%, for an annualized return of 2.36%.

Where is Sarepta incorporated? Sarepta became an Oregon corporation in 1980, under the name AntiVirals, Inc. and in 2013 reincorporated in Delaware. Sarepta is engineering solutions for rare diseases with science that is on the forefront of precision genetic medicine. Our platforms include: gene therapy, RNA technologies, and gene editing.